.png)
Ophthalmic Drugs Market by Drug Class, Product Type, Distribution Channel - Global Industry Analysis & Forecast to 2027
Published On : April 2020 Pages : 160 Category: Pharma & Healthcare Report Code : HC0410221
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Ophthalmic Drugs Market by Drug Class (Anti-glaucoma Drug, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Retinal Drug, Anti-infective Drugs, Other Drugs) Product Type (OTC Drug, Prescription Drug), Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Ophthalmic Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
-
- Aerie Pharmaceuticals Inc.
- Allergan
- Bausch Health Companies Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Hoya Corporation
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co. Ltd
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Ophthalmic Drugs Market, By Class Type, Estimates and Forecast, 2017-2027 ($Million)
o Anti-glaucoma Drug
o Dry eye Drug
o Ophthalmic Anti-allergy/Inflammatory
o Retinal Drug
o Anti-infective Drugs
o Other Drugs
· Ophthalmic Drugs Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o OTC Drug
o Prescription Drug
· Ophthalmic Drugs Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Hospital Pharmacies
o Drug Stores
o Online Pharmacies
o Others
· Ophthalmic Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Aerie Pharmaceuticals Inc.
o Allergan
o Bausch Health Companies Inc.
o Bayer AG
o F. Hoffmann-La Roche Ltd
o Hoya Corporation
o Novartis AG
o Pfizer Inc.
o Regeneron Pharmaceuticals Inc.
o Santen Pharmaceutical Co. Ltd
· Ophthalmic Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Ophthalmic Drugs Market, By Class Type
5.1. Introduction
5.2. Global Ophthalmic Drugs Revenue and Market Share by Class Type (2017-2021)
5.2.1. Global Ophthalmic Drugs Revenue and Revenue Share by Class Type (2017-2021)
5.3. Anti-glaucoma Drug
5.3.1. Global Anti-glaucoma Drug Revenue and Growth Rate (2017-2021)
5.4. Dry eye Drug
5.4.1. Global Dry eye Drug Revenue and Growth Rate (2017-2021)
5.5. Ophthalmic Anti-allergy/Inflammatory
5.5.1. Global Ophthalmic Anti-allergy/Inflammatory Revenue and Growth Rate (2017-2021)
5.6. Retinal Drug
5.6.1. Global Retinal Drug Revenue and Growth Rate (2017-2021)
5.7. Anti-infective Drugs
5.7.1. Global Anti-infective Drugs Revenue and Growth Rate (2017-2021)
5.8. Other Drugs
5.8.1. Global Other Drugs Revenue and Growth Rate (2017-2021)
6. Ophthalmic Drugs Market, By Product Type
6.1. Introduction
6.2. Global Ophthalmic Drugs Revenue and Market Share by Product Type (2017-2021)
6.2.1. Global Ophthalmic Drugs Revenue and Revenue Share by Product Type (2017-2021)
6.3. OTC Drug
6.3.1. Global OTC Drug Revenue and Growth Rate (2017-2021)
6.4. Prescription Drug
6.4.1. Global Prescription Drug Revenue and Growth Rate (2017-2021)
7. Ophthalmic Drugs Market, By Distribution Channel
7.1. Introduction
7.2. Global Ophthalmic Drugs Revenue and Market Share by Distribution Channel (2017-2021)
7.2.1. Global Ophthalmic Drugs Revenue and Revenue Share by Distribution Channel (2017-2021)
7.3. Hospital Pharmacies
7.3.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2021)
7.4. Drug Stores
7.4.1. Global Drug Stores Revenue and Growth Rate (2017-2021)
7.5. Online Pharmacies
7.5.1. Global Online Pharmacies Revenue and Growth Rate (2017-2021)
7.6. Others
7.6.1. Global Others Revenue and Growth Rate (2017-2021)
8. Ophthalmic Drugs Market, By Region
8.1. Introduction
8.2. Global Ophthalmic Drugs Revenue and Market Share by Regions
8.2.1. Global Ophthalmic Drugs Revenue by Regions (2017-2021)
8.3. North America Ophthalmic Drugs by Countries
8.3.1. North America Ophthalmic Drugs Revenue and Growth Rate (2017-2021)
8.3.2. North America Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2021)
8.3.3. United States
8.3.3.1. United States Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.4. Canada
8.3.4.1. Canada Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.5. Mexico
8.3.5.1. Mexico Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4. Europe Ophthalmic Drugs by Countries
8.4.1. Europe Ophthalmic Drugs Revenue and Growth Rate (2017-2021)
8.4.2. Europe Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2021)
8.4.3. Germany
8.4.3.1. Germany Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.4. France
8.4.4.1. France Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.5. UK
8.4.5.1. UK Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.6. Russia
8.4.6.1. Russia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.7. Italy
8.4.7.1. Italy Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5. Asia-Pacific Ophthalmic Drugs by Countries
8.5.1. Asia-Pacific Ophthalmic Drugs Revenue and Growth Rate (2017-2021)
8.5.2. Asia-Pacific Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2021)
8.5.3. China
8.5.3.1. China Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.4. Japan
8.5.4.1. Japan Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.5. Korea
8.5.5.1. Korea Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.6. India
8.5.6.1. India Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6. South America Ophthalmic Drugs by Countries
8.6.1. South America Ophthalmic Drugs Revenue and Growth Rate (2017-2021)
8.6.2. South America Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2021)
8.6.3. Brazil
8.6.3.1. Brazil Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.4. Argentina
8.6.4.1. Argentina Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.5. Columbia
8.6.5.1. Columbia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7. Middle East and Africa Ophthalmic Drugs by Countries
8.7.1. Middle East and Africa Ophthalmic Drugs Revenue and Growth Rate (2017-2021)
8.7.2. Middle East and Africa Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2021)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.5. Egypt
8.7.5.1. Egypt Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.6. Nigeria
8.7.6.1. Nigeria Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.7. South Africa
8.7.7.1. South Africa Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.8. Turkey
8.7.8.1. Turkey Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
9. Company Profiles
9.1. Aerie Pharmaceuticals Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Allergan
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Bausch Health Companies Inc.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Bayer AG
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. F. Hoffmann-La Roche Ltd
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Hoya Corporation
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Novartis AG
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Pfizer Inc.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Regeneron Pharmaceuticals Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Santen Pharmaceutical Co. Ltd
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Ophthalmic Drugs Market Forecast (2022-2027)
10.1. Global Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2022-2027)
10.2. Ophthalmic Drugs Market Forecast by Regions (2022-2027)
10.2.1. North America Ophthalmic Drugs Market Forecast (2022-2027)
10.2.1.1. United States Ophthalmic Drugs Market Forecast (2022-2027)
10.2.1.2. Canada Ophthalmic Drugs Market Forecast (2022-2027)
10.2.1.3. Mexico Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2. Europe Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2.1. Germany Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2.2. France Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2.3. UK Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2.4. Russia Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2.5. Italy Ophthalmic Drugs Market Forecast (2022-2027)
10.2.2.6. Rest of Europe Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3. Asia-Pacific Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3.1. China Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3.2. Japan Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3.3. Korea Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3.4. India Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3.5. Southeast Asia Ophthalmic Drugs Market Forecast (2022-2027)
10.2.3.6. Rest of Asia-Pacific Ophthalmic Drugs Market Forecast (2022-2027)
10.2.4. South America Ophthalmic Drugs Market Forecast (2022-2027)
10.2.4.1. Brazil Ophthalmic Drugs Market Forecast (2022-2027)
10.2.4.2. Argentina Ophthalmic Drugs Market Forecast (2022-2027)
10.2.4.3. Columbia Ophthalmic Drugs Market Forecast (2022-2027)
10.2.4.4. Rest of South America Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5. Middle East and Africa Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.1. Saudi Arabia Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.2. United Arab Emirates Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.3. Egypt Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.4. Nigeria Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.5. South Africa Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.6. Turkey Ophthalmic Drugs Market Forecast (2022-2027)
10.2.5.7. Rest of Middle East and Africa Ophthalmic Drugs Market Forecast (2022-2027)
10.3. Ophthalmic Drugs Market Forecast by Class Type (2022-2027)
10.3.1. Ophthalmic Drugs Forecast by Class Type (2022-2027)
10.3.2. Ophthalmic Drugs Market Share Forecast by Class Type (2022-2027)
10.4. Ophthalmic Drugs Market Forecast by Product Type (2022-2027)
10.4.1. Ophthalmic Drugs Forecast by Product Type (2022-2027)
10.4.2. Ophthalmic Drugs Market Share Forecast by Product Type (2022-2027)
10.5. Ophthalmic Drugs Market Forecast by Distribution Channel (2022-2027)
10.5.1. Ophthalmic Drugs Forecast by Distribution Channel (2022-2027)
10.5.2. Ophthalmic Drugs Market Share Forecast by Distribution Channel (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Ophthalmic Drugs Revenue and Revenue Share by Class Type (2017-2019)
Figure Global Anti-glaucoma Drug Revenue and Growth Rate (2017-2019)
Figure Global Dry eye Drug Revenue and Growth Rate (2017-2019)
Figure Global Ophthalmic Anti-allergy/Inflammatory Revenue and Growth Rate (2017-2019)
Figure Global Retinal Drug Revenue and Growth Rate (2017-2019)
Figure Global Anti-infective Drugs Revenue and Growth Rate (2017-2019)
Figure Global Other Drugs Revenue and Growth Rate (2017-2019)
Table Global Ophthalmic Drugs Revenue and Revenue Share by Product Type (2017-2019)
Figure Global OTC Drug Revenue and Growth Rate (2017-2019)
Figure Global Prescription Drug Revenue and Growth Rate (2017-2019)
Table Global Ophthalmic Drugs Revenue and Revenue Share by Distribution Channel (2017-2019)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2019)
Figure Global Drug Stores Revenue and Growth Rate (2017-2019)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Ophthalmic Drugs Revenue by Regions (2017-2019)
Figure North America Ophthalmic Drugs Growth Rate (2017-2019)
Figure North America Ophthalmic Drugs Revenue and Growth Rate (2017-2019)
Figure North America Ophthalmic Drugs by Countries (2017-2019)
Figure North America Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure United States Ophthalmic Drugs Growth Rate (2017-2019)
Figure United States Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Ophthalmic Drugs Growth Rate (2017-2019)
Figure Canada Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Ophthalmic Drugs Growth Rate (2017-2019)
Figure Mexico Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Ophthalmic Drugs Growth Rate (2017-2019)
Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2017-2019)
Figure Europe Ophthalmic Drugs by Countries (2017-2019)
Figure Europe Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Germany Ophthalmic Drugs Growth Rate (2017-2019)
Figure Germany Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Ophthalmic Drugs Growth Rate (2017-2019)
Figure France Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Ophthalmic Drugs Growth Rate (2017-2019)
Figure UK Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Ophthalmic Drugs Growth Rate (2017-2019)
Figure Russia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Ophthalmic Drugs Growth Rate (2017-2019)
Figure Italy Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Ophthalmic Drugs Growth Rate (2017-2019)
Figure Rest of Europe Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Ophthalmic Drugs Growth Rate (2017-2019)
Figure Asia-Pacific Ophthalmic Drugs Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Ophthalmic Drugs by Countries (2017-2019)
Figure Asia-Pacific Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure China Ophthalmic Drugs Growth Rate (2017-2019)
Figure China Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Ophthalmic Drugs Growth Rate (2017-2019)
Figure Japan Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Ophthalmic Drugs Growth Rate (2017-2019)
Figure Korea Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Ophthalmic Drugs Growth Rate (2017-2019)
Figure India Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Ophthalmic Drugs Growth Rate (2017-2019)
Figure Southeast Asia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Ophthalmic Drugs Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Ophthalmic Drugs Growth Rate (2017-2019)
Figure South America Ophthalmic Drugs Revenue and Growth Rate (2017-2019)
Figure South America Ophthalmic Drugs by Countries (2017-2019)
Figure South America Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Ophthalmic Drugs Growth Rate (2017-2019)
Figure Brazil Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Ophthalmic Drugs Growth Rate (2017-2019)
Figure Argentina Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Ophthalmic Drugs Growth Rate (2017-2019)
Figure Columbia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Ophthalmic Drugs Growth Rate (2017-2019)
Figure Rest of South America Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Ophthalmic Drugs Growth Rate (2017-2019)
Figure Middle East and Africa Ophthalmic Drugs Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Ophthalmic Drugs by Countries (2017-2019)
Figure Middle East and Africa Ophthalmic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Ophthalmic Drugs Growth Rate (2017-2019)
Figure Saudi Arabia Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Ophthalmic Drugs Growth Rate (2017-2019)
Figure United Arab Emirates Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Ophthalmic Drugs Growth Rate (2017-2019)
Figure Egypt Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Ophthalmic Drugs Growth Rate (2017-2019)
Figure Nigeria Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Ophthalmic Drugs Growth Rate (2017-2019)
Figure South Africa Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Ophthalmic Drugs Growth Rate (2017-2019)
Figure Turkey Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Ophthalmic Drugs Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Table Aerie Pharmaceuticals Inc. Ophthalmic Drugs Financial Overview
Table Allergan Ophthalmic Drugs Financial Overview
Table Bausch Health Companies Inc. Ophthalmic Drugs Financial Overview
Table Bayer AG Ophthalmic Drugs Financial Overview
Table F. Hoffmann-La Roche Ltd Ophthalmic Drugs Financial Overview
Table Hoya Corporation Ophthalmic Drugs Financial Overview
Table Novartis AG Ophthalmic Drugs Financial Overview
Table Pfizer Inc. Ophthalmic Drugs Financial Overview
Table Regeneron Pharmaceuticals Inc. Ophthalmic Drugs Financial Overview
Table Santen Pharmaceutical Co. Ltd Ophthalmic Drugs Financial Overview
Figure Global Ophthalmic Drugs Revenue (Millions USD) and Growth Rate (2019-2027)
Table Ophthalmic Drugs Market Forecast by Regions (2019-2027)
Figure North America Ophthalmic Drugs Market Forecast (2019-2027)
Figure United States Ophthalmic Drugs Market Forecast (2019-2027)
Figure Canada Ophthalmic Drugs Market Forecast (2019-2027)
Figure Mexico Ophthalmic Drugs Market Forecast (2019-2027)
Figure Europe Ophthalmic Drugs Market Forecast (2019-2027)
Figure Germany Ophthalmic Drugs Market Forecast (2019-2027)
Figure France Ophthalmic Drugs Market Forecast (2019-2027)
Figure UK Ophthalmic Drugs Market Forecast (2019-2027)
Figure Russia Ophthalmic Drugs Market Forecast (2019-2027)
Figure Italy Ophthalmic Drugs Market Forecast (2019-2027)
Figure Rest of Europe Ophthalmic Drugs Market Forecast (2019-2027)
Figure Asia-Pacific Ophthalmic Drugs Market Forecast (2019-2027)
Figure China Ophthalmic Drugs Market Forecast (2019-2027)
Figure Japan Ophthalmic Drugs Market Forecast (2019-2027)
Figure Korea Ophthalmic Drugs Market Forecast (2019-2027)
Figure India Ophthalmic Drugs Market Forecast (2019-2027)
Figure Southeast Asia Ophthalmic Drugs Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Ophthalmic Drugs Market Forecast (2019-2027)
Figure South America Ophthalmic Drugs Market Forecast (2019-2027)
Figure Brazil Ophthalmic Drugs Market Forecast (2019-2027)
Figure Argentina Ophthalmic Drugs Market Forecast (2019-2027)
Figure Columbia Ophthalmic Drugs Market Forecast (2019-2027)
Figure Rest of South America Ophthalmic Drugs Market Forecast (2019-2027)
Figure Middle East and Africa Ophthalmic Drugs Market Forecast (2019-2027)
Figure Saudi Arabia Ophthalmic Drugs Market Forecast (2019-2027)
Figure United Arab Emirates Ophthalmic Drugs Market Forecast (2019-2027)
Figure Egypt Ophthalmic Drugs Market Forecast (2019-2027)
Figure Nigeria Ophthalmic Drugs Market Forecast (2019-2027)
Figure South Africa Ophthalmic Drugs Market Forecast (2019-2027)
Figure Turkey Ophthalmic Drugs Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Ophthalmic Drugs Market Forecast (2019-2027)
Figure Global Ophthalmic Drugs Forecast by Class Type (2019-2027)
Figure Global Ophthalmic Drugs Market Share Forecast by Class Type (2019-2027)
Figure Global Ophthalmic Drugs Forecast by Class Type (2019-2027)
Figure Global Ophthalmic Drugs Forecast by Product Type (2019-2027)
Figure Global Ophthalmic Drugs Market Share Forecast by Product Type (2019-2027)
Figure Global Ophthalmic Drugs Forecast by Product Type (2019-2027)
Figure Global Ophthalmic Drugs Forecast by Distribution Channel (2019-2027)
Figure Global Ophthalmic Drugs Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Ophthalmic Drugs Forecast by Distribution Channel (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|